Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:2927 (Glytoucan)

Id:ad04ba70-7ea3-5304-b80b-fb700a372596

Glytoucan:G29972TM

Results found

Linked to

	Label	Description
	label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G29972TM-GLYCOSEQ00125329 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G18947DS-GLYCOSEQ00108865 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G18947DS-GLYCOSEQ00108866 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 has canonical residue n-glycan core b-d-manp c Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00002209 CUI has saccharide label:2927 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:2927 has canonical residue n-glycan core d-glcnac a Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G29972TM-GLYCOSEQ00125329 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G18947DS-GLYCOSEQ00108865 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 has glycosequence GLYGEN.GLYCOSEQUENCE:G18947DS-GLYCOSEQ00108866 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 has canonical residue n-glycan core b-d-manp c

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000027 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00002209 CUI has saccharide label:2927

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:2927 has canonical residue n-glycan core d-glcnac a

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.